California 2023-2024 Regular Session

California Senate Bill SB21

Introduced
12/5/22  
Refer
1/18/23  
Introduced
12/5/22  
Introduced
12/5/22  
Refer
2/23/23  
Refer
1/18/23  
Refer
2/23/23  
Refer
2/23/23  
Report Pass
3/29/23  
Report Pass
3/29/23  
Report Pass
5/18/23  
Refer
3/29/23  
Refer
3/29/23  
Engrossed
5/24/23  
Report Pass
5/18/23  
Report Pass
5/18/23  
Engrossed
5/24/23  
Refer
6/1/23  
Engrossed
5/24/23  
Report Pass
6/13/23  
Refer
6/1/23  
Refer
6/1/23  
Report Pass
6/13/23  
Refer
1/17/24  
Refer
6/13/23  
Refer
6/13/23  
Refer
5/2/24  
Refer
1/17/24  
Refer
1/17/24  
Refer
5/2/24  
Refer
5/2/24  

Caption

Controlled substances.

Impact

The legislation modifies the criminal justice approach towards those charged with drug-related offenses. It allows individuals guilty of certain crimes involving fentanyl to participate in a treatment program instead of facing jail or prison time. This program must be developed by a drug addiction expert and approved by the court. Furthermore, upon successful completion of the treatment, individuals may have their charges dismissed, thus providing a second chance and incentivizing rehabilitation over punishment. The bill aims to treat the underlying issues of addiction rather than simply reflecting a punitive approach to drug offenses, potentially relieving the burden on the prison system in California.

Summary

Senate Bill 21, known as Alexandras Law, addresses the growing crisis surrounding fentanyl in California. The bill incorporates significant amendments to existing laws governing the possession, sale, and transport of controlled substances, specifically targeting offenses related to fentanyl and its analogs. It mandates that individuals convicted of related crimes receive advisories about the dangers of distributing controlled substances and the potential for homicide charges should someone die from their actions. This advisory is a critical addition designed to raise awareness among offenders regarding the lethal consequences of their actions, particularly in relation to fentanyl, which has been linked to numerous overdose deaths.

Sentiment

The sentiment regarding SB 21 is generally supportive, particularly from advocacy groups focused on drug rehabilitation and public health. Proponents argue that the bill represents a progressive step toward addressing the fentanyl epidemic in a more compassionate and effective way. However, some concerns have been raised about the potential for leniency towards those who continue to engage in illegal activities under the guise of treatment options. Critics contend that while treatment is essential, it should not replace accountability for drug distribution crimes, particularly in cases that lead to fatalities. This aspect has sparked a polarized debate among lawmakers and constituents.

Contention

Notable points of contention around SB 21 revolve around the balance between public safety and rehabilitation opportunities for offenders. Critics worry that the bill may unintentionally encourage the distribution of fentanyl if individuals perceive treatment as an easy way out of serious crimes. Additionally, the requirement that the advisory about the consequences of drug distribution must be formally noted serves as a double-edged sword; while aiming to instill responsibility, it also raises questions about how this information will be utilized in future legal proceedings. The discussions highlight the complex interplay between criminal justice reform, public health initiatives, and community safety.

Companion Bills

No companion bills found.

Previously Filed As

CA SB848

Civil actions: parties and postponements.

CA AB2484

Courts: juveniles: remote proceedings.

CA SB133

Courts.

CA AB133

Courts.

CA SB241

Civil actions.

CA AB170

Courts.

CA SB170

Courts.

CA SB22

Crimes.

CA AB1103

Controlled substances: research.

CA SB1588

Relating to controlled substances.

Similar Bills

CA SB22

Crimes.

CA AB890

Controlled substances: probation.

CA SB1381

Crimes: child pornography.

CA SB904

Controlled substances: treatment.

CA AB33

Fentanyl Misuse and Overdose Prevention Task Force.

CA SB46

Controlled substances: treatment.

CA SB19

Fentanyl Misuse and Overdose Prevention Task Force.